Cm Management, LLC Spectrum Pharmaceuticals Inc Transaction History

Cm Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 04, 2023	BUY	$0.65 - $1.31 $81,250 - $163,750	125,000 Added 18.52%	800,000 $768,000
Q4 2022 Feb 09, 2023	SELL	$0.32 - $0.52 $40,000 - $65,000	-125,000 Reduced 15.63%	675,000 $249,000
Q3 2022 Nov 04, 2022	BUY	$0.43 - $1.56 $86,000 - $312,000	200,000 Added 33.33%	800,000 $344,000
Q1 2022 May 09, 2022	BUY	$0.63 - $1.59 $283,500 - $715,500	450,000 Added 300.0%	600,000 $774,000
Q4 2021 Feb 02, 2022	SELL	$1.27 - $2.42 $190,500 - $363,000	-150,000 Reduced 50.0%	150,000 $191,000
Q1 2021 May 12, 2021	BUY	$2.9 - $4.09 $145,000 - $204,500	50,000 Added 20.0%	300,000 $978,000
Q4 2020 Feb 04, 2021	BUY	$3.38 - $5.14 $845,000 - $1.29 Million	250,000 New	250,000 $853,000

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Cm Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Cm Management, LLC with notifications on news.